13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001398344-23-020603
Total Value
$4.9M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VACCITECH PLC | BRNS | 642,204 | $2.0M | 40.85% |
| 2 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $1.6M | 33.20% |
| 3 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $1.3M | 25.95% |